Latest Views & News

Sadly, My Big Disappointment for Medical Pioneer Comes with the Territory

By Malcolm Stacey | Thursday 14 February 2019


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Hello Share Tasters. I now always add a warning to any piece I do on medical pioneers. Rewards can be huge if a new drug comes on the market, but the licensing authorities have understandably to be very cautious. A share which I commended to your further research a month ago has just suffered a huge disappointment. US regulators have currently rejected the company’s new iclaprim drug…

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

|